Verastem, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that Robert Weinberg, Ph.D., Verastem scientific cofounder and chair of the Scientific Advisory Board, and Christoph Westphal, M.D., Ph.D., Verastem cofounder, Chairman and ... (more)
http://www.businesswire.com/news/topix/20130227005480/en
http://www.businesswire.com/news/topix/20130227005480/en
No comments:
Post a Comment